Google Inc vs Hinge Health Inc. Class A Common Stock — how do they compare? Google Inc trades at $337.92 (market cap $4.30T), while Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B). The key difference: Google Inc is far larger — about 507.1× Hinge Health Inc. Class A Common Stock's market cap, and Google Inc pays a 0.25% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Google Inc for 138 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| GOOG | HNGE | |
|---|---|---|
Market Cap | $4.30T | $8.48B |
Volume | 14,394,061 | 879,799 |
Sector | Media | Health |
52-Week High | $399.06 | $105.14 |
52-Week Low | $251.34 | $31.17 |
Typical Hold Time | 138 Days | 0 Days |
Enterprise Value | $4.19T | $8.10B |
Dividend Yield | 0.25% | — |
Signals from Pluang's Aura AI — not financial advice
Alphabet (GOOG) trades at $343.65, down 1.52% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust fundamentals with Q2 2026 EPS of $9.11 beating expectations by 218%, revenue growth accelerating to $402.84B in 2025, and net income margin expanding to 54.77%. Recent news highlights significant AI investments and legal challenges.
Alphabet presents a compelling investment case with strong earnings momentum and dominant market position, though investors face risks from aggressive capital expenditure, potential negative free cash flow, and ongoing securities litigation. The consensus price target of $435.24 suggests 27% upside potential from current levels.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.
Read more on GOOG →Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →